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ABSTRACT
Zika virus (ZIKV) infection in the human central nervous system (CNS) causes Guillain–Barre
syndrome, cerebellum deformity, and other diseases. Astrocytes are immune response cells in
the CNS and an important component of the blood–brain barrier. Consequently, any damage to
astrocytes facilitates the spread of ZIKV in the CNS. Connective tissue growth factor/
Nephroblastoma overexpressed gene family 1 (CCN1), an important inflammatory factor secreted
by astrocytes, is reported to regulate innate immunity and viral infection. However, the mechan-
ism by which astrocyte viral infection affects CCN1 expression remains undefined. In this study, we
demonstrate that ZIKV infection up-regulates CCN1 expression in astrocytes, thus promoting
intracellular viral replication. Other studies revealed that the cAMP response element (CRE) in
the CCN1 promoter is activated by the ZIKV NS3 protein. The cAMP-responsive element-binding
protein (CREB), a transacting factor of the CRE, is also activated by NS3 or ZIKV. Furthermore,a
specific inhibitor of CREB, i.e. SGC-CBP30, reduced ZIKV-induced CCN1 up-regulation and ZIKV
replication. Moreover, co-immunoprecipitation, overexpression, and knockdown studies con-
firmed that the interaction between NS3 and the regulatory domain of CaMKIIα could activate
the CREB pathway, thus resulting in the up-regulation of CCN1 expression and enhancement of
virus replication. In conclusion, the findings of our investigations on the NS3-CaMKIIα-CREB-CCN1
pathway provide a foundation for understanding the infection mechanism of ZIKV in the CNS.
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Introduction
Zika virus (ZIKV), an arbovirus of the genus Flavivirus
within the familyFlaviviridae, has recently garnered
attentionas it can cause cerebellum deformity in new-
borns [1]. In the brain, ZIKV preferentially infects
neural stem cells, astrocytes, oligodendrocyte precur-
sors, and microglia [2]. Astrocytes are important
immune response cells in various neurotropic viral
infections [3–6]. They respond to central nervous sys-
tem(CNS) injury and degenerative diseases [7,8].
Considerable evidence suggests that astrocytes areim-
portant in CNS homeostasis and are typically involved
in maintaining, supporting, and nourishing neurons
and in interactions with the endothelia to generate
and maintain the blood–brain barrier(BBB) [9,10].
The interaction between ZIKV and astrocytes is of
interest to researchers [11–16].
CCN1, also called cysteine-rich protein 61 (Cyr61), is a
matricellular secreted protein of the cysteine rich 61/
connective tissue growth factor/nephroblastoma overex-
pressed (CCN) gene family. CCN1 is secreted by reactive
astrocytes [17]. It is distributed in a dot shape in the cell
membrane, extracellular matrix, and in cytoplasmic peri-
nuclear areas where the endoplasmic reticulum is loca-
lized at a high density [18–20]. CCN1 regulates multiple
cellular functions through integrin receptors and co-
receptors, such as heparin sulfate proteoglycans receptors
and low-density lipoprotein receptor-related proteins
[21]. Additionally, it regulates cell proliferation, adhesion,
migration, differentiation, apoptosis, senescence, and
gene expression [21]. Recently, CCN1 has been impli-
cated as a pro-inflammatory factor involved in the regula-
tion of inflammatory molecules [22,23]. It is generally
known that CCN1 expression is up-regulated in viral or
bacterial infection [24–27]. The presence of CCN1 also
facilitates virus replication [25]. Therefore, it is important
to investigate the role of CCN1 in the replication and
dissemination of ZIKV in the CNS.
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Hitherto, multiple pathways have been implicated in
the regulation of CCN1 expression, including thecAMP-
responsive element-binding protein(CREB) [28]. CREB, a
nuclear transcription factor, can be activated by various
kinases including theCa2+/calmodulin-dependent protein
kinase II (CaMKII) and can promote the expression of
genes containing the cAMP response element (CRE) [29].
CaMKII, a Ca2+/calmodulin-dependent Ser/Thr protein
kinase, has four isoforms: CaMKIIα, CaMKIIβ, CaMKIIγ,
and CaMKIIδ [30]. Anincrease in the intracellular Ca2+
concentration leads to the binding of Ca2+ ions to calmo-
dulin (CaM), resulting in the activation of CaMKII. Upon
activation, this enzyme autophosphorylates Thr286, a
process that confers Ca2+-independent activity on the
kinase and significantly increases its affinity for CaM
[31]. In addition, CaMKII-CREB signallingis critical in
the regulation of synaptic plasticity [32,33].
To explore the interactions between ZIKV and
CCN1 in astrocytes, we first confirm the role of
CCN1 in viral replication and reveal the specific
mechanisms by which ZIKV regulates CCN1 expres-
sion. These findings provide a foundation for under-
standing the pathogenesis of ZIKV in the CNS.
Materials and methods
Cells culture
Vero cells (African Green Monkey kidney) (CCL-81,
American Type Culture Collection) were cultured in
minimum essential medium (MEM) (Life
Technologies) supplemented with 10% fetal bovine
serum (FBS) (Gibco). CCF-STTG1 cells (Human
Astrocytoma) (ATCC-CRL-1718) were cultured in
Roswell Park Memorial Institute 1640 medium
(RPMI-1640) (Life Technologies) supplemented with
10% FBS (Gibco). HEK293T cells (ATCC-CRL-3216)
were cultured in Dulbecco’s modified Eagle’s medium
(DMEM)(Life Technologies) supplemented with 10%
FBS (Gibco). All cells were cultured at 37°C in an
atmosphere of 5% CO2. Aedes albopictus C6/36 cells
(ATCC-CRL-1660) were cultured in RPMI-1640 sup-
plemented with 10% FBS (Gibco) at 28°C in an atmo-
sphere of 5% CO2.
Virus
ZIKV (Zika virus/SZ01/2016/China, GenBank:
KU866423.2) was obtained from the Wuhan Institute
ofVirology, Chinese Academy of Science [34] and was
propagated in C6/36 cells.Viral titer was determined by
TCID50 assay; 50 µl of virus suspension was added to
450 µl of MEM. A series of 10-fold dilutions up to a
concentration of 10−11 was prepared with the MEM.
Subsequently, 100 µl of each dilution was loaded in
quadruplicate into a 96-well plate of Vero cells, fol-
lowed by 1.5-h incubation for viral absorption.
Subsequently, the supernatant containing virus was
removed and replaced with fresh MEM. Four to seven
days were required to complete the viral infection cycle
when no new cytopathogenic effects (CPEs) appeared
in the wells. The CPE was observed, and the number of
wells associated with the CPE was entered into the Reed
& Muench calculation calculator software [35]. UV-
ZIKV was prepared by placing samples on ice, 70 cm
below a 30-W UV lamp for 30 min.
Plasmid construction
The cDNAs of human CCN1WT (CCN1) and nonsecre-
tory signal-CCN1mut (NS-CCN1) were obtained from
CCF-STTG1 total RNA by RT-PCR using the CCN1
and NS-CCN1 primers, as shown in Table 1. The RT-
PCR fragments were cloned into a pcDNA3.1 (+) vector
and digested with NheI and BamHI (TaKaRa).
The expression plasmids of ZIKV nonstructural pro-
teins, including pCAGGS-Flag-NS1, pCAGGS-Flag-NS2A,
pCAGGS-Flag-NS2B, pCAGGS-Flag-NS3, pCAGGS-Flag-
NS4A, pCAGGS-Flag-NS4B, and pCAGGS-Flag-NS5,
were constructed by cloning the corresponding coding
region of the viral proteins fromZIKV cDNA and inserting
them into the multiple cloning sites of pCAGGS.
To generate luciferase reporter plasmids of the
CCN1 promoter with different regulatory elements,
different lengths of promoter regions were amplified
from the CCF-STTG1 genomic DNA by PCR using
the p-2299 (−2299-+191), p-2001 (−2001-+191), p-895
(−895-+191), p-409 (−409-+191), p-40 (−40-+191), and
p-CRE-mut (p-CRE-mutant, the full-length CCN1 pro-
moter deleted −67–60 bases) primers, as shown in
Table 1. The p-CRE-mut fragment is constructed by
overlap PCR. The primers p-CRE-mut-p-2299–68 and
p-CRE-mut-59-+191 are used for amplifyingthe PCR
products −2299–68 and −59-+191 respectively, and
the two fragments are mixed equally for overlap exten-
sion of p-CRE-mut fragments lacking −67–60 bases
with primers of p-2299.The PCR fragments were cloned
into pGL3 luciferase reporter vectors (Promega) and
digested with KpnI and BglII (TaKaRa). Subsequently,
the cloned fragments were verified by sequencing.
A series of human CaMKIIα mutants were con-
structed by inserting PCR fragments amplified from
human cDNA library into the pcDNA3.1(+) vector and
digesting with NheI and HindIII. The fragments and
their corresponding PCR primers are listed in Table 1.
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CCF-STTG1 cells transfection
CCF-STTG1 cells were plated in an appropriate culture
dish. When the plated cells reached approximately 70–
80% confluence, the cells were transfected using
LipofectamineTM 3000 (Invitrogen), according to the
manufacturer’s instructions.
For RNA interference (siRNA) transfection, si-
CaMKIIα(targeting sequence in Table 1) and nonspe-
cific scrambled siRNA were purchased from China’s
RIBOBIO Co., Ltd. The CCF-STTG1 cells were placed
into 6-well plates, andtransfection was performed
under optimal conditions of 40-60% confluence. Each
transfection was performed with 50-nM siRNA using
LipofectamineTM 3000 (Invitrogen), according to the
manufacturer’s instructions.
Virus infection, inhibitor, and antibody treatments
CCF-STTG1 cells were infected with ZIKV at a multi-
plicity of infection (MOI) of three tissue infections 50%
dose (TCID50)/cell (ZIKV group) or sham-treated with
RPMI-1640 medium (mock group). For inhibitor experi-
ments, the cells were infected with ZIKV for 2h in the
presence of the indicated inhibitor, washed with RPMI-
1640 medium, and placed in a medium containing 10%
FBS along with fresh inhibitor, SGC-CBP30 (MedChem
Express). For antibody neutralization experiments,the
cells were infected with ZIKV for 2h, washed with
RPMI-1640 medium, and placed in medium with 10%
FBS containing anti-CCN1 antibody (Santa Cruz).
Ethics approval and participation consent
All animal experiments were performed in strict accor-
dance with the regulations described in the Guide for the
Care and Use of Laboratory Animals issued by the
Ministry of Science and Technology of the People’s
Republic of China. All efforts were made to minimize
suffering. Animal protocols complied with the
Guidelines for Animal Care approved by the Laboratory
Animal Care and Use Committee at the Wuhan Institute
of Virology, Chinese Academy of Sciences (Wuhan,
China) (approval number: WIVA07201704; approval
date 1 September 2016).
Animal experiments
C57BL/6 mice deficient in IFN I and II receptors (AG6
mouse, ifnagr-/-) were obtained from the Institute
Pasteur of Shanghai, Chinese Academy of Sciences and
bred in specific pathogen-free conditions at the Wuhan
Institute of Virology. Nine-week-old AG6 mice were
intraperitoneally injected with 105 TCID50 of ZIKV in
100 µL of phosphate-buffered saline (PBS). Nine 3-week-
old AG6 mice fromthe mock group were administered
PBS by the same route. The mice were sacrificed on days
2 and 5 post-infection; the whole brain of three mice in
each group was dissected and homogenized in 1-mL
cold PBS. Subsequently, 50μLof the homogenizing liquid
was added to 950μL TRIzol and frozen at −80°C. On day
5 post-infection, three mice in each group were admi-
nistered 4% paraformaldehyde (PFA) systemic perfusion
Table 1. Oligos used in vector construction and RT-qPCR assay and RNA interference.
PCR products/purpose Forward premier(5ʹ→3ʹ) Reverse premier(5ʹ→3ʹ)
CCN1 CTAgctagcATGAGCTCCCGCATCGCCAG CGCggatccTTAGTCCCTAAATTTGTGAATGTC
NS-CCN1 CTAgctagcATGACCTGCCCCGCTGCCTGC CGCggatccTTAGTCCCTAAATTTGTGAATGTC
p-2299 CGGggtaccCCCCATCCCCAACCTCCAA GGAagatctGCGACGAAGACGCCAACAAG
p-2001 CGGggtaccCAAATAGAAAAGACGCCAC GGAagatctGCGACGAAGACGCCAACAAG
p-895 CGGggtaccGGCTGGAACTAAAGTGGGAACCT GGAagatctGCGACGAAGACGCCAACAAG
p-409 CGGggtaccCCCTCACGACCCTCCAACTAC GGAagatctGCGACGAAGACGCCAACAAG
p-40 CGGggtaccCCGCCGGCCCGTATAAAAG GGAagatctGCGACGAAGACGCCAACAAG
p-CRE-mut-p-2299–68 CGGggtaccCCCCATCCCCAACCTCCAA AGGCGCCGCGTGTTGCAGGCTCTGTCTGCGCGTTCC
p-CRE-mut-p-59-+191 CTGCAACACGCGGCGCCTCCGCCGGCCCGTATAAAAG GGAagatctGCGACGAAGACGCCAACAAG
HA-CaMKIIα 1(1–478) CTAgctagcATGTACCCATACGACGTCCCAGACTACGCTGCCACCATCACCTGCACCC CCCaagcttTCAGTGGGGCAGGACGGA
HA-CaMKIIα 261 (261–
478)
CTAgctagcATGTACCCATACGACGTCCCAGACTACGCTACAGCTGCCGAAGCCCTT CCCaagcttTCAGTGGGGCAGGACGGA
HA-CaMKIIα 280 (280–
478)
CTAgctagcATGTACCCATACGACGTCCCAGACTACGCTTGCATGCACAGACAGGAGA CCCaagcttTCAGTGGGGCAGGACGGA
HA-CaMKIIα 301 (301–
478)
CTAgctagcATGTACCCATACGACGTCCCAGACTACGCTGGAGCCATTCTCACCACG CCCaagcttTCAGTGGGGCAGGACGGA
HA-CaMKIIα 315 (315–
478)
CTAgctagcATGTACCCATACGACGTCCCAGACTACGCTGGAGGGAAGAGTGGGGG CCCaagcttTCAGTGGGGCAGGACGGA
HA-CaMKIIα 341 (341–
478)
CTAgctagcATGTACCCATACGACGTCCCAGACTACGCTGAAGACACCAAAGTGCGG CCCaagcttTCAGTGGGGCAGGACGGA
si-CaMKIIα targeting GGACTTCCATCGATTCTAT
ZIKV detecting AARTACACATACCARAACAAAGTG TCCRCTCCCYCTYTGGTCTTG
human-gapdh q-PCR GTCTCCTCTGACTTCAACAGCG ACCACCCTGTTGCTGTAGCCAA
mouse-gapdh q-PCR AACGACCCCTTCATTGAC CCACGACATACTCAGCAC
human-ccn1 q-PCR GAATCTACCAAAACGGGGAAAG GGGTTGTATAGGATGCGAGGCT
mouse-ccn1 q-PCR CAGAATCTACCAAAACGGGGA GGTTCGGTGCCAAAGACAGG
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after anesthesia, and the whole brain was removed for
paraffin embedding.
Immunofluorescence
Brains were embedded in paraffin wax after gradient
ethanol dehydration and xylene transparency and, sub-
sequently, sectioned using a microtome. Additionally,
36 h post-infection, the CCF-STTG1 cells were fixed in
4% PFA and permeabilised in PBS containing 0.5%
Triton X-100 and 20-mM glycine.
The standard immunofluorescence staining protocol
was followed for tissue or cell staining. Primary antibodies
included anti-ZIKV envelope (ZIKV-E) proteinantibody
(Biofront) (1:200), anti-glial fibrillary acidic protein
(GFAP) antibody (1:100) (Proteintech), anti-p-CREB
(Ser133) antibody (1:100) (Abcam),and anti-CCN1 anti-
body (1:100) (Proteintech). All primary antibodies were
incubated with the corresponding secondary antibodies.
Counterstaining was performed using4, 6-diamidino-2-
phenylindole (DAPI).Fluorescent images of the cells were
capturedusing a Nikon fluorescence microscope (Tokyo,
Japan). Images of the tissue were acquired usinga whole-
slide digital panoramic scanner (3D-Histech, Budapest,
Hungary).
Luciferase assays
HEK293T cells were grown to 40–50% confluence in
12-well plates and co-transfected with an expression
plasmid, a luciferase reporter plasmid, and pRL-TK
(Renilla luciferase, internal control) using ProFection
calcium phosphate reagents, according to the manufac-
turer’s instructions (Promega). Subsequently, 24–48 h
post-transfection, the cells were collected and washed
once with cold PBS. Passive lysis buffer (Promega) was
subsequently added to the cells. After 15 min, super-
natants were collected following centrifugation at
12,000 × g for 3 min, and relative luciferase activity
was measured with the Dual-Luciferase Reporter Assay
System according to the manufacturer’s instructions
(Promega).
RNA isolation, cDNA synthesis, and RT-qPCR
The culture supernatant of 300 μL was placed in 700-μL
LS TRIzol (Life Technologies), and the RNA in the
culture supernatant was extracted according to the
instructions. The culture supernatant was removed,
1 mL TRIzol (Life Technologies) was added, and RNA
was extracted from the cell, according to the instruc-
tions. TRIzolreagent was used to isolatemouse brain
total RNA after homogenization. First-strand cDNA
was synthesized using PrimeScript™ RT Reagent Kit
with gDNA Eraser (Perfect Real Time) (TaKaRa). For
RT-qPCR, cDNA derived from 50-ng RNA was ampli-
fied in a 20-µL volume using SYBR GreenER qPCR
SuperMix for ABI PRISM (Invitrogen). The primers
of human-gapdh, mouse-gapdh, human-ccn1, and
mouse-ccn1, and the ZIKV, shown in Table 1, were
used for RT-qPCR. The RT-qPCR conditions were set
to 95°C for 3 min, 40 cycles at 95°C for 10 s, and 60°C
for 45 s. To evaluate the copy number of ZIKV and
CCN1 in the samples, the RT-qPCR threshold cycle
value was set according to the standard curve obtained
with plasmids containing DNA sequences amplified
from the corresponding ZIKV or CCN1 cDNA at serial
dilutions ranging from 1 × 103 to 1 × 108copies/mL.
TAP purification and mass spectrometry
TAP purification assays were performed according to
the standard manufacturer’s instruction (Stratagene). In
brief, 293T cells were transfected with pNTAP-A-NS3
or pNTAP-A control vector. After 36 h post-transfec-
tion, cells were harvested and lysed. ZIKV NS3-host
protein complexes were first purified using washed
streptavidin resin and then washed calmodulin resin.
The protein complexes were eluted by calmodulin elu-
tion buffer (CEB) and rotated the tube at 4ºC for
30 min followed by precipitation by trichloroacetic
acid (TCA) method. The precipitated proteins were
identified by mass spectrometry.
Co-IP assay
HEK293T cells were co-transfected with pcDNA-HA-
CaMKIIα and pCAGGS-Flag-NS3 or pCAGGS-Flag-
NS5 using ProFection calcium phosphate reagents
(Promega). Subsequently, 24–36 h post-transfection,
the cells were collected using western and IP buffer
(Beyotime, Jiangsu, China) containing PMSF protease
inhibitor according to the manufacturer’s instructions.
Whole-cell extract (30 μL) was used as input; the
remainder was divided into two equal parts and incu-
bated with the Flag antibody and IgG, separately, at 4°C
overnight with gentle rotation. Protein G magnetic
beads (Invitrogen) were added into the lysates and
incubated for 2–3 h according to the manufacturers’
instructions. Precipitates were washed five times with
TBST buffer, and the proteins were eluted by boiling
the beads for 5 min in 1× SDS sample buffer. Eluted
proteins and input whole-cell extracts were analyzed by
western blot.
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Western blot
Cell lysates were prepared using RIPA buffer (Beyotime,
Jiangsu, China) supplemented with PMSF protease inhi-
bitor and phosphatase inhibitor cocktail (Roche) accord-
ing to the manufacturer’s instructions. Equal amounts of
cellular protein extracts were diluted in sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
sample buffer, heated at 100°C for 15 min, and subjected
to 12% SDS-PAGE. Proteins were electroblotted onto
Immobilon-P polyvinylidene fluoride membranes
(Millipore). Subsequently, nonspecific binding sites
were blocked in Tris-buffered saline (TBS) containing
5% (w/v) nonfat milk powder. All antibodies were
diluted in 2.5% (w/v) nonfat milk powder in TBS. The
blots were subsequently analyzed by incubation with the
indicated antibody against CCN1 (1:1000) (Proteintech),
CREB (1:1000) (Abcam), p-CREB (1:5000) (Abcam),
CaMKIIα (1:1000) (Santa Cruz), p-CaMKIIα (1:1000)
(Santa Cruz), ZIKV-E protein (1:2000) (Biofront), Flag
(1:1000), HA (1:1000),or beta-actin (1:1000) (ComWei),
followed by an appropriate secondary antibody. After
adding the Immobilon western chemiluminescent HRP
substrate (Millipore), the blots were visualized and ana-
lyzed using the Bio-Rad imaging system.
Statistical analysis
Each experiment was repeatedthree times. Statistical
analyses were performed using the GraphPad Prism
6.0 software (GraphPad Software, San Diego, CA).
Data are expressed as mean ± standard deviation
(SD). Probability values of less than 0.05, 0.01, and
0.001 were considered statistically significant and
marked with *, **, and ***, respectively, in figures.
Results
ZIKV infects astrocytoma CCF-STTG1 cells and
astrocytes in vivo
To determine whether ZIKV could infect astrocytoma and
astrocytes, the following two experiments were performed.
CCF-STTG1, a human astrocytoma cell line, was used for
in vitro studies [36,37]. Immunofluorescence staining
demonstrated the presence of ZIKV-Eproteinpositive pro-
ducts in CCF-STTG1 cells (Figure 1(a)).An in vivo infec-
tion experiment was conducted as well. Nine-week-old
AG6 mice were intraperitoneally injected with 105
TCID50 of ZIKV. Onday 5 post-infection, the entire brain
was perfused with 4% PFA and subsequently stripped and
analyzed by immunofluorescence staining. Parts of the
astrocytes expressing the characteristic marker, GFAP,
were found positive for ZIKV-E protein (Figure 1(b)).
Comprehensively, these results indicate that ZIKV can
infect astrocytoma in vitro and astrocytes in vivo, which is
consistent with thefindings of previous reports [38,39].
ZIKV promotes CCN1 expression in astrocytoma
CCF-STTG1 cells and astrocytes in vivo
To analyze the expression profile of CCN1 during ZIKV
infection in CCF-STTG1 cells and astrocytes, RT-qPCR
(double-standard curves method), western blot, and
immunofluorescence staining were performed. The cells
were infected with ZIKV at an MOI of 3 (TCID50/cell).
The results indicated that as infection time increased,
intracellular viral RNA content also increased inside the
cell, peaking at 72h post-infection (Figure 2(a)). In vitro
extracellular viral RNA indicated a clear increase at 60h
post-infection that also peaked at 72hpost-infection
(Figure 2(a)).This proved that the virus was released after
60 h post-infection. Furthermore, these results revealed
that ZIKV could replicate and be released in CCF-STTG1
cells. CCN1mRNA and protein expression levels increased
in the ZIKV group compared withthose in the mock group
(Figure 2(b,c)). This indicates that the ZIKV infection of
human astrocytoma CCF-STTG1 cells in vitro up-regulates
CCN1 expression. In vivo, ZIKV could infect the brain of
AG6 mice. To study the effect of ZIKV infection on the
expression of CCN1 in mouse brain, the whole brain of
mice was stripped and homogenized; RT-qPCR results
showed that CCN1 expression at the mRNA levels was
up-regulated in the ZIKV group on days 2 and 5 post-
infection, compared with that of the mock group
(Figure 2(d)). Immunofluorescence staining of brain par-
affin sections showed that CCN1 positive products were
distributed in the cytoplasm and extracellular matrix of the
astrocytes. Compared with those of themock group, CCN1
positive products in the ZIKV group increased significantly
(Figure 2(e)). This indicates that ZIKV infection up-regu-
lated CCN1 expression in mouse astrocytes in vivo.
Therefore, CCF-STTG1 cells were used as an in vitro
model to investigate the mechanism underlying ZIKV
infection-mediated CCN1 expression in astrocytes.
CCN1 facilitates ZIKV replication
To examine the role of CCN1 in ZIKV infection, CCN1
plasmids, theirnonsecreted mutant NS-CCN1, and the
control pcDNA3.1(+) were transfected into CCF-
STTG1 cells, separately. The results show that com-
pared with the control group, CCN1 mRNA was highly
expressed in CCN1 and NS-CCN1 groups (Figure 3(a)).
But,we found that the CCN1 mRNA in NS-CCN1
group was lower than that in CCN1 group
(Figure 3(a)). Subsequently, 6 h post-transfection, the
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cells were infected with ZIKV at an MOI of 3.
Toanalyse the effect of CCN1 on viral replication and
release, intracellular and extracellular ZIKV RNA were
measured by RT-qPCR analysis 60 h post-infection. A
significant increase in intracellular viral RNA was
detected in the CCN1 group compared with that in
the NS-CCN1 and control groups (Figure 3(b)).
Extracellular ZIKV RNA levels of the CCN1, NS-
CCN1, and control groups exhibited no significant
difference (Figure 3(b)). ZIKV-E protein was detected
using western blot to investigate the effects of CCN1 on
ZIKV infection. CCF-STTG1 cells overexpressing
CCN1 or NS-CCN1 were infected with ZIKV at an
MOI of 3 (TCID50/cell). Subsequently, 24 h post-infec-
tion, an increase in ZIKV-E protein expression was
detected in the CCN1 group compared with that in
the control and NS-CCN1 groups (Figure 3(c)). Of
note, compared with the control group, ZIKV-E
Figure 1. ZIKV infects CCF-STTG1 cells in vitro and astrocytes in the brain of AG6 mice in vivo. (a) CCF-STTG1 cells were infected with
ZIKV at an MOI of 3 (TCID50/cell). Subsequently, 24-h post-infection, the cells were used for immunofluorescence analysis. The
experiment was repeated three times. ZIKV-E (red), DAPI (blue).10×; (b) Sagittal sections of the brains of AG6 mice on day 5 post-
infection. Three mice per group were perfused and paraffin-embedded. GFAP (green), ZIKV-E (red), DAPI (blue).48.4× magnification.
(Bar = 50 μm).
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Figure 2. ZIKV promotes CCN1 expression in CCF-STTG1 cells and in mouse brain astrocytes. (a) and (b) MOI = 3TCID50/cell. Double
standard curve method was used for RT-qPCR. The formula of the standard curve is as follows: human-gapdh y = −0.240x + 10.99,
human-ccn1 y = −0.221x + 10.27, ZIKV RNA y = −0.272x + 10.96. (a) Expression profiles of ZIKV RNA in intra- and culture
supernatant CCF-STTG1 cells. (b) Expression profiles of CCN1mRNA post-infection in CCF-STTG1 cells. (c) Expression profiles of CCN1
and ZIKV-E protein in CCF-STTG1 cells. (d) Expression profiles of ZIKV RNA and CCN1 mRNA in the brain of mice. On days 2 and 5
post-infection, the whole brain of ZIKV-infected mice and mock-treated mice were stripped and total RNA were extracted and
analyzed using RT-qPCR (double standard curve method). The formula of the standard curve is as follows: mouse-gapdh
y = −0.3025x + 11.048, mouse-ccn1 y = −0.2234x +10.124, ZIKV RNA y = −0.2721x + 10.966. (e) Immunofluorescence staining of
CCN1 and GFAP in the brain of mice. CCN1 (red), GFAP (green), DAPI (blue). (Bar = 50 μm). Each experiment was repeated three
times. Statistical analyses were performed using GraphPad Prism 6.0 software. Data are expressed as the mean ± standard deviation
(SD) (*, P < 0.05; **, P < 0.01; ***, P < 0.001).
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protein expression in NS-CCN1 groups also showed a
small increase (Figure 3(c)). It is suggested that CCN1
may have other intercellular targets on the viral
replication.This indicates that CCN1 expression can
enhance intracellular ZIKV replication and that CCN1
secretion is important for this process.
Figure 3. CCN1 promotes ZIKV replication in CCF-STTG1 cells. (A&B) CCN1, NS-CCN1, and pcDNA3.1(+) were transfected in CCF-
STTG1 cells, separately. Subsequently, 6 h post-transfection, the cells were infected with ZIKV (MOI = 3TCID50/cell). Cells and
supernatants were harvested 60 h post-infection. (a) Intracellular CCN1 mRNA levels were measured by RT-qPCR analysis (compara-
tive delta–delta Ct). b) Intracellular and extracellular ZIKV RNA levels were measured by RT-qPCR analysis (comparative delta–delta
Ct). (c) CCF-STTG1 cells were transfected with CCN1 or NS-CCN1 expression plasmids, and subsequently infected with ZIKV (MOI = 3
(TCID50/cell)), and cell lysates were harvested 24 h post-infection. The CCN1 and ZIKV-E protein level relative to beat actinin three
experiments were summarized in the bar graph below. (d)&(e) CCF-STTG1 cells were infected with ZIKV for 2 h, followed by the
addition of 1 µg or 2 µg of H-78 in the culture supplied with 1.5-mL complete medium. (d) CCF-STTG1 cells were harvested 36 h
post-infection for western blot. Densitometry from ZIKV E blots normalized for beta-actin were labeled below the blots (e) CCF-
STTG1 cells were harvested 36 h post-infection for RT-qPCR. Double standard curve method was used for RT-qPCR. The formula of
the standard curve is as follows: human-gapdh y = −0.438x + 14.02, human-ccn1 y = −0.262x + 10.90, ZIKV RNA y = −0.243x +
10.42. Each experiment was repeated three times. Statistical analyses were performed using GraphPad Prism 6.0 software. Data are
expressed as the mean ± standard deviation (SD) (*, P < 0.05; **, P < 0.01; ***, P < 0.001).
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CCN1 is a secreted protein. Therefore, we used H-78
(Santa Cruz sc-13,100), a CCN1 antibody, to inhibit the
activation of downstream CCN1 signals [40,41].
Following infection with ZIKV for 2 h, 1µg or 2µg of
H-78 was added in 1.5 mL of complete medium. CCF-
STTG1 cells were harvested 36h post-infection. We
found that H-78 blocked the synthesis of ZIKV-E pro-
tein in a dose-dependent manner (Figure 3(d)). This
suggests that CCN1 downstream signaling is important
for the enhancement of ZIKV infection.
ZIKV NS3 protein activates the CRE in the CCN1
promoter and induces CREB phosphorylation and
CCN1 expression
To investigate whether viral invasion or viral replication
could induce increased CCN1 expression, we used UV
inactivated ZIKV UV-ZIKV in infection assays. To inac-
tivate ZIKV, we used direct UV irradiation, a conven-
tionalmethod used to inactivate viruses [42]. After 30min
of UV irradiation, UV-ZIKV was used to infect CCF-
STTG1 cells and ZIKV-E protein was not detected 24 h
post-infection (Figure 4(a)). However, ZIKV RNA was
detected 12 h post-infection in the UV-ZIKV group, but
the amount was much lower than that of the ZIKV group
(Figure 4(b)), indicating that the virus had lost its ability
to replicate. This indicates that UV-ZIKV was effectively
inactivated. Compared to findings by the mock group and
ZIKV group, enhancement of CCN1 expression was not
observed in the UV-ZIKV group (Figure 4(a,b)). This
suggests that ZIKV replication is required to stimulate
CCN1 expression.
To investigate which nonstructural proteins are
involved in the regulation of CCN1 expression, we
used the dual luciferase reporter system. Different non-
structural protein expression plasmids were transiently
transfected into HEK293T cells with the full-length
CCN1 promoter (p-2299) and TK plasmids. The
expression of nonstructural proteins was detected
using western blot. The results showed that NS3 could
significantly enhance the activation of the full-length
CCN1 promoter (Figure 4(c)).
To identify the CCN1 promoter elements affected by
NS3, promoter reporter,plasmids containing different
elements were constructed (Figure 4(d)). The results
showed that promoter activation was lost when the
promoter was deficient in the CRE element, suggesting
that the CRE of CCN1 is the key target element of NS3
(Figure 4(e)).
To determine whether CREB, the nuclear transcrip-
tion factor of CRE, was activated by NS3, we harvested
Flag-NS3-transfected CCF-STTG1 cells 24 h post-trans-
fection for western blot. The results demonstrated that
NS3 enhanced the phosphorylation of CREB at
Ser133as well as CCN1 expression (figure 4(f)).
CREB phosphorylation affects CCN1 expression in
ZIKV infection
Sendai virus (SV) mediates the activation of the tran-
scription factor CREB [43]. To investigate whether
CREB was activated during ZIKV infection thus leading
to enhanced CCN1 protein expression, ZIKV-infected
CCF-STTG1 cells were harvested 6 h post-infection.
The level of CREB Ser133 phosphorylation was
enhanced 6h post-infection (Figure 5(a)). Further
experiments were performed using SGC-CBP30, a
highly potent and selective CREBBP/EP300 bromodo-
main inhibitor. SGC-CBP30 binds CREB and acts as a
scaffold to stabilize additional protein interactions with
the transcription complex. SGC-CBP30 reduced the
expression of CCN1 and ZIKV-E protein 24 h post-
infection (Figure 5(b)). These results suggest that ZIKV
infection in CCF-STTG1 cells activates the CCN1 pro-
tein via the CREB pathway.
Immunofluorescence results indicate that Ser133-
phosphorylated CREB appeared primarily in the
nucleus of GFAP-labeled astrocytes and that Ser133-
phosphorylated CREB positive cells increased in the
ZIKV group compared with those of the mock group
(Figure 5(c)).
NS3 binds to the regulatory domain of CaMKIIα to
enhance phosphorylation at Thr286
Using tandem affinity purification (TAP) binding mass
spectrometry, CaMKIIα was identified as a target pro-
tein that interacts with ZIKV NS3.The top-15 proteins
with the highest possibility of interacting with ZIKV
NS3 are listed in Table 2. The specific interaction of
CaMKIIα with NS3 was further verified by Co-IP.
HEK293T cells were co-transfected with HA-CaMKIIα
and Flag-NS3 or Flag-NS5 and harvested for Co-IP
assaywith anti-Flag antibodyat 28 h post-transfection.
The results showed that CaMKII binds to NS3 but not
to NS5 (Figure 6(a)), suggesting that the binding is
specific. To verify the effect of NS3 on CaMKIIα activ-
ity, we examined the phosphorylation of CaMKIIα at
Thr286 24h post-transfection. The results indicate that
NS3 enhanced the phosphorylation of CaMKIIα at
Thr286 (Figure 6(b)).
CaMKIIαis composed of an N-terminal catalytic
domain (residues 1–260), a regulatory domain (residues
261–309), and a C-terminal association domain (resi-
dues 310–478) [44]. To determine the binding site of
NS3 on CaMKIIα, aseries of CaMKIIα mutant
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plasmids, including 261–478, 280–478, 301–478, 315–
478, and 341–478 residues, were constructed for the
Co-IP assay (Figure 6(c)). The results showed that
residues 261–478 and 280–478 but not residues 301–
478, 315–478, and 341–478 interacted with NS3
(Figure 6(d)). This suggests that the NS3 interaction
site is located between residues 280 and 300, which is
within the regulatory domain of CaMKIIα. It is note-
worthy that the interaction between mutant 1–478 and
NS3 is much stronger than that between mutants 261–
478 and 280–478, indicating an additional interaction
between NS3 and the catalytic domain in addition to
the regulatory domain (Figure 6(d)).
NS3 in cooperation with CaMKIIα activates CRE and
up-regulates CCN1 transcription
It has been reported that CaMKII can activate the
CRE of a target gene promoter via CREB phosphor-
ylation [45,46]. To determine whether CaMKIIα or
the combination of CaMKIIα with NS3 can
Figure 4. NS3 protein of ZIKV activates the CRE in the CCN1 promoter and induces CREB phosphorylation and CCN1 expression. (a)
and (b) CCF-STTG1 cells were infected with ZIKV or UV-ZIKV for 2 h. (a) Cells were harvested 24 h post-infection for western blot
analysis. (b) Cells were harvested 12 h post-infection for RT-qPCR analysis. Densitometry from CCN1 blots normalized for beta-actin
were labeled below the blots. Double standard curve method was used for RT-qPCR. The formula of the standard curve is as follows:
human-gapdh y = −0.438x + 14.02, human-ccn1 y = −0.262x + 10.90, ZIKV RNA y = −0.243x + 10.42. (c) HEK293T cells were grown
to 40–50% confluence in 12-well plates and co-transfected with 1500 ng of pCAGGS-Flag-NS, 250 ng of p-2299, and 50 ng of pRL-TK
using ProFection calcium phosphate reagents. Subsequently, 24–48 h post-transfection, the cells were collected for luciferase
detection. (d) Diagram of series CCN1 promoter mutant containing various cis-elements. (e) HEK293T cells were grown in 12-well
plates and co-transfected with 1500 ng of pCAGGS-Flag-NS3, 250 ng of p-2299, p-2001, p-895, p-409, p-40 or p-CRE-mut, and 50 ng
of pRL-TK using ProFection calcium phosphate reagents. Subsequently, 24–48 h post-transfection, the cells were collected for
luciferase detection. (f) CCF-STTG1 cells were transfected with 2000 ng Flag-NS3 per well in a 6-well plate using LipofectamineTM
3000. The cells were subsequently harvested for western blot at 24 h post-transfection.The relative p-CREB and CCN1 protein levelin
three experiments were summarized in the bar graph on the right. Each experiment was repeated three times. Statistical analyses
were performed using GraphPad Prism 6.0 software. Data are expressed as the mean ± standard deviation (SD). (*, P < 0.05; ***,
P < 0.001).
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activatethe CRE of the CCN1 promoter, CaMKIIα
and NS3 expression plasmids, pRL-TK, and p-2299
or p-409 were co-transfected into HEK293T cells.
Subsequently, 48 h post-transfection, double lucifer-
ase assays were performed. Compared with control
group transfected pCAGGS-flag and pcDNA3.1,
CaMKIIα activated both the full-length promoter
p-2299 and the mutant promoter p-409 containing
only the CRE, whereas NS3 appeared to enhance this
activation (Figure 7(a)). Further experiments were
performed to assess whether the interaction of NS3
with CaMKIIα was responsible for the enhanced
Figure 5. Phosphorylation of CREB Ser133 affects CCN1 expression and ZIKV replication. (a) CCF-STTG1 cells were infected with ZIKV
at MOI = 3 TCID50/celland harvested 6 h post-infection for western blot. Densitometry ratioofp-CREB blots toCREB were labeled
below the blots (b) CCF-STTG1 cells were infected with ZIKV in the presence of the inhibitor SGC-CBP30 (1 µM), washed with 1× PBS,
and placed in RPMI-1640 medium with 10% FBS containing 1-µM SGC-CBP30. The cells were harvested 24 h post-infection for
western blot. The relative CCN1 protein level in three experiments were summarized in the bar graph on the right and expressed as
mean ± S.D (c) On day 5 post-infection, the brain was stripped and analyzed by immunofluorescence staining. GFAP (green), p-CREB
(red), DAPI (blue). (Bar = 50 μm). Each experiment was repeated three times. Statistical analyses were performed using GraphPad
Prism 6.0 software. Data are expressed as the mean ± standard deviation (SD). (***, P < 0.001).
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CCN1 CRE activation. Various amounts of CaMKIIα
expression plasmids together with NS3, pRL-TK, and
p-409 were co-transfected into HEK293T cells. The
cells were harvested 24 h post-transfection for dual
reporter luciferase assays. The results showed that the
enhanced activation of CCN1 CRE in the
NS3&CaMKIIα groups was positively correlated
with the amount of transfected CaMKIIα expressing
plasmids (Figure 7(b)). Subsequently, the amount of
CCN1 mRNA24 h post-transfection was detected by
RT-qPCR. The results showed that, compared with
the NS3 or CaMKIIα groups, the expression levels of
CCN1 mRNA in the NS3&CaMKIIα groups were
positively correlated with the transfection dose of
the HA-CaMKIIα-expressing plasmids (Figure 7(c)).
This demonstrates that NS3 cooperates with
CaMKIIα to up-regulate CCN1 expression through
the CRE on the CCN1 promoter.
CaMKIIα enhances CREB phosphorylation, CCN1
expression, and ZIKV replication
When CCF-STTG1 cells were infected with ZIKV,
enhanced phosphorylation of CaMKIIα at Thr286 was
detected (Figure 8(a)). When the ZIKV-infected CCF-
STTG1 cells were transfected with NC or si-CaMKIIα,
the phosphorylation level of CaMKIIα Thr286 and
CREBSer133 decreased and the expressions of CCN1
and ZIKV-E protein reduced as well. Meanwhile, in
uninfected cells, si-CaMKIIα does not significantly
affect the CCN1 expression compared with the negative
control (NC) (Figure 8(b)). These results indicate that,
only in ZIKV infection, a decreased CaMKIIα can
reduce the phosphorylation of CREB at Ser133, CCN1
expression, and virus replication. When the HA-
CaMKIIα-transfected CCF-STTG1 cells were infected
with ZIKV, the phosphorylation of CREB Ser133
showed an increasing trend that correlated with the
transfection dose of HA-CaMKIIα plasmids; moreover,
a unique up-regulating trend was observed for the
expression of CCN1 protein.The ZIKV-E protein
shows an increasing trend as well (Figure 8(c)).
However, the expression of CCN1 was not affected in
the uninfected cells (Figure 8(d)). These results suggest
that, in ZIKV infection, CaMKIIα has a distinctive
regulatory role in CREB activation and CCN1 expres-
sion that facilitates virus replication. Therefore,
CaMKIIα is critical in ZIKV-enhanced CREB phos-
phorylation, CCN1 expression, and ZIKV replication.
Discussion
As a pro-inflammatory factor, CCN1 expression can be
enhanced by CVB3, oncolytic herpes simplex virus-1
(HSV-1)and influenza A virus (IAV) infection
[25,26,47]. In this study, we found that ZIKV also
enhanced the expression of CCN1 in the astroglioma
cell line CCF-STTG1. Furthermore, this enhancement
was observed in the astrocytes of AG6 mice, a well-
known model of ZIKV infection [48]. Astrocytes are an
important type of glial cell and are critical for brain
development and function [49]. Additionally, astrocytes
participate in regulating synapse formation and
immune responses in the brain [6,10]. Therefore, reg-
ulatory changes in the inflammatory factor CCN1
secreted by astrocytes and their role during neurotropic
virus infection were investigated.
It has been reported that CCN1 expression aids the
replication of coxsackievirus B3 (CVB3) [25]. Our
study showed that CCN1 promoted ZIKV replication
in CCF-STTG1 cells. In the presence of an anti-CCN1
monoclonal antibody, ZIKV replication was reduced in
a dose-dependent manner. These results suggest that
CCN1 likely binds to receptors on the cell membrane
Table 2. Partial mass spectrometry results for TAP-tagged ZIKV NS3.
Number Accession Name
1 sp|P49327|FAS_HUMAN Fatty acid synthase OS = Homo sapiens GN = FASN PE = 1 SV = 3
2 sp|Q92598|HS105_HUMAN Heat shock protein 105 kDa OS = Homo sapiens GN = HSPH1 PE = 1 SV = 1
3 sp|P06576|ATPB_HUMAN ATP synthase subunit beta, mitochondrial OS = Homo sapiens GN = ATP5B PE = 1 SV = 3
4 tr|B0QY89|B0QY89_HUMAN Eukaryotic translation initiation factor 3 subunit L OS = Homo sapiens GN = EIF3L PE = 1 SV = 1
5 sp|P12004|PCNA_HUMAN Proliferating cell nuclear antigen OS = Homo sapiens GN = PCNA PE = 1 SV = 1
6 tr|A0A087X2I1|
A0A087X2I1_HUMAN
26S protease regulatory subunit 10B OS = Homo sapiens GN = PSMC6 PE = 1 SV = 1
7 sp|Q99714|HCD2_HUMAN 3-hydroxyacyl-CoA dehydrogenase type-2 OS = Homo sapiens GN = HSD17B10 PE = 1 SV = 3
8 tr|Q5H928|Q5H928_HUMAN 3-hydroxyacyl-CoA dehydrogenase type-2 OS = Homo sapiens GN = HSD17B10 PE = 1 SV = 1
9 sp|P09543|CN37_HUMAN 2ʹ,3ʹ-cyclic-nucleotide 3ʹ-phosphodiesterase OS = Homo sapiens GN = CNP PE = 1 SV = 2
10 tr|H0YBR5|H0YBR5_HUMAN Eukaryotic translation initiation factor 3 subunit E (Fragment) OS = Homo sapiens GN = EIF3E PE = 1 SV = 1
11 sp|Q9UQM7|KCC2A_HUMAN Calcium/calmodulin-dependent protein kinase type II subunit alpha OS = Homo sapiens GN = CAMK2A
PE = 1 SV = 2
12 sp|P50851|LRBA_HUMAN Lipopolysaccharide-responsive and beige-like anchor protein OS = Homo sapiens GN = LRBA PE = 1 SV = 4
13 tr|Q5T4U5|Q5T4U5_HUMAN Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain, isoform CRA_a OS = Homo sapiens GN = ACADM
PE = 1 SV = 1
14 sp|P11310|ACADM_HUMAN Medium-chain specific acyl-CoA dehydrogenase, mitochondrial OS = Homo sapiens GN = ACADM PE = 1 SV = 1
15 sp|Q9UNY4|TTF2_HUMAN Transcription termination factor 2 OS = Homo sapiens GN = TTF2 PE = 1 SV = 2
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and activates downstream pathways that regulate ZIKV
replication. It has been reported that CCN1 can activate
multiple signaling pathways via binding to different
integrin receptors [50], such as PI3K/Akt/NF-кB [51],
ERK1/ERK2 MAPK [52], β-catenin-TCF/Lef [53], and
AP-1-dependent pathways [54]. Interestingly, the non-
secretory mutant of CCN1also promotes the replication
of ZIKV; it has been suggested that other intercellular
targets of viral replication may have existed. The down-
stream CCN1 pathways that regulate ZIKV replication
is worthy of investigation.
Our study mainly focuses on the mechanism by
which ZIKV enhances CCN1 expression in astrocytes.
The CCN1 promoter contains a variety of cis-regulatory
elements and is regulated by various factors including
growth factors, hormones, and cytokines [55]. We
Figure 6. NS3 binds to the regulatory domain of CaMKIIα to enhance phosphorylation at Thr286. (a) HEK293T cells were co-
transfected with 3000 ng HA-CaMKIIα and 3000 ng Flag-NS3 or Flag-NS5 in 60-mm dishes using ProFection calcium phosphate
reagents. The cells were harvested for Co-IP experiments 28 h post-transfection. (b) CCF-STTG1 cells were transfected with 2000 ng
Flag-NS3 per well in a 6-well plate using LipofectamineTM 3000. These cells were harvested for western blot 24 h post-transfection.
The relative level of p-CaMKIIα in three experiments were summarized in the bar graph on the right and expressed as mean ± S.D .
(c) The schematic map of a series of HA-CAMKIIα mutants was shown. (d) HEK293T cells were co-transfected with 1500 ng HA-
CaMKIIα or CaMKIIα mutant and 1500 ng Flag-NS3 using ProFection calcium phosphate reagents. The cells were subsequently
harvested for Co-IP experiments 28 h post-transfection (*, HA-CaMKIIα specific band; the other band is the antibody heavy chain).
Control is pcDNA3.1(+), 1 is HA-CAMKIIα 1–478, 261 is HA-CAMKIIα mutant 261–478, 280 is HA-CAMKIIα mutant 280–478, 301 is HA-
CAMKIIα mutant 301–478, 315 is HA-CAMKIIα mutant 315–478, 341 is HA-CAMKIIα mutant 341–478. Each experiment was repeated
three times. (*, Flag-NS3 specific band; **, HA-CaMKIIα specific band; ***, Flag-NS3 specific band; the other band is the Flag antibody
heavy chain).
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constructed a reporter plasmid, p-2299, containing the
full-length CCN1 promoter to screen for viral proteins
that activate CCN1 expression. Our study showed that
UV-ZIKV could not induce the enhancement of CCN1
expression in CCF-STTG1 cells, suggesting that struc-
tural proteins may not be involved in the regulation of
CCN1 expression. Therefore, the regulatory ability of
seven nonstructural proteins on CCN1 promoter p-
2299 was studied. Our results showedthat NS3 was
important in this process. NS3 protein is a multifunc-
tional protein with serine protease, nucleoside-tripho-
sphatase-dependent RNA helicase, adenosine
triphosphatase, and RNA 5-triphosphatase activities;
additionally, it is important for viral replication [56].
Figure 7. NS3 in cooperation with CaMKIIα activates CRE and up-regulates CCN1 transcription. (a) The pcDNA3.1(+) (900 ng) and
pCAGGS-Flag (800 ng) (as a control) or HA-CaMKIIα (900 ng) and Flag-NS3 (800 ng) or HA-CaMKIIα (900 ng) and pCAGGS-Flag
(800 ng), together with pRL-TK, and p-2299 or p-409 were co-transfected into HEK293T cells using ProFection calcium phosphate
reagents. Subsequently, 48 h post-transfection, double luciferase assays were performed. The results were presented as Relative
Luciferase Activity (firefly luciferase activity/renilla luciferase activity). (b) Various doses of HA-CaMKIIα, 1000-ng Flag-NS3, p-409, and
pRL-TK were transfected into HEK293T cells using ProFection calcium phosphate reagents. The cells were harvested 24 h post-
transfection for dual reporter luciferase assays. The results were presented as Relative Luciferase Activity (firefly luciferase activity/
renilla luciferase activity). (c) Various doses of HA-CaMKIIα and 1000-ng Flag-NS3 were used for transient transfection into CCF-STTG1
cells using LipofectamineTM 3000 reagent. The cells were harvested 24 h post-transfection for RT-qPCR (comparative delta–delta Ct).
Each experiment was repeated three times. Statistical analyses were performed using GraphPad Prism 6.0 software. Data are
expressed as the mean ± standard deviation (SD)(*, P < 0.05; **, P < 0.01; ***, P < 0.001).
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Figure 8. CaMKIIα regulates CREB Ser133 phosphorylation and affects CCN1 expression and ZIKV replication. (a) CCF-STTG1 cells
were seeded in 35-mm dishes. After 16–18 h of culture, the cells were infected with ZIKV (MOI = 3) for 2 h. The cells were harvested
6 h or 36 h post-infection for western blot. Densitometry ratio of p-CaMKIIa blots to CaMKIIa were labeled below the blots (b) si-
CaMKIIα (50-nM per well) was transfected into CCF-STTG1 cells in a 6-well plate using LipofectamineTM 3000. After transfection for
43–46 h, the cells were inoculated with RPMI or ZIKV (MOI = 3). Subsequently, the cells were harvested 6 h or 24 h post-infection for
western blot. Densitometry from p-CaMKIIa and CCN1 blots normalized for beta-actin were labeled below the blots.The relative level
of ZKIV E and CCN1 protein of three experiments were quantized and summarized in the bar graph on the right(c, d) HA-CaMKIIα (0–
1.5-μg) per well was transfected into CCF-STTG1 cells in a 6-well plate using LipofectamineTM 3000. After transfection for 8–10 h, the
cells were inoculated with ZIKV (MOI = 3) (c) or mock infected with RPMI-1640 (d) . Subsequently, the cells were harvested 6 h or
36 h post-infection for western blot. The relative level of p-CREB, CCN1 and ZKIV E protein of three experiments were quantized and
summarized in the bar graphs below.The blots were visualized and analyzed using the Bio-Rad imaging system. Statistical analyses
were performed using GraphPad Prism 6.0 software. Data are expressed as the mean ± standard deviation (SD) (*, P < 0.05; **,
P < 0.01; ***, P < 0.001).
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However, the NS3 protein can only function with the
assistance of the NS2B protein [57]; therefore, the role
of NS2B-NS3 in the expression of CCN1 cannot be
excluded. Additionally, owing to the low expression
level of NS2B, as shown in Figure 4(c), the possible
role of NS2B in the regulation of CCN1 cannot be ruled
out. Thus, whether viral proteins other than NS3 reg-
ulate CCN1 expression necessitates further study.
Previous studies have indicated that the promoter
region of CCN1 contains multiple response elements,
including CArG, FAP, Oct, TBE1&2, AP1, and CRE
[58]. As shown in Figure 2(b,c), the CCN1 level varied
in the mock group. This phenomenon has been reported
in a previous study [58], and it may be related to the
CArG element in the CCN1 promoter, which is regu-
lated by the SRF serum response factor. When serum is
gradually used in the culture medium, the activity of
CCN1 promoter decreases and the expression of CCN1
promoter decreases gradually. However, the CRE regu-
latory element in the CCN1 promoter activated by ZIKV
is enough to activate the expression. Other promoter
mutant studies indicated that the CRE on the CCN1
promoter was regulated by NS3. CREB is a trans-acting
factor of the CRE. CREB is activated through the phos-
phorylation of Ser133, which increases its association
with CREB-binding proteins or other transcription coac-
tivators that increase the rate of transcription [59]. In
our study, the phosphorylation of CREB Ser133 was
enhanced during ZIKV infection or NS3 overexpression.
Furthermore, SGC-CBP30, a CREBBP/EP300 inhibitor,
could inhibit the ZIKV-induced enhancement of CCN1
expression and ZIKV replication. This suggests that
CREB phosphorylation and CREB binding to CREBBP/
EP300 are critical to ZIKV-mediated CCN1 expressions
in astrocytes. Moreover, the CREB Ser133 phosphoryla-
tion state is determined by the activation levels of CREB
kinases such as PKA, RSK, calmodulin kinase, and
MSK1/2 [60]. Thus, the signaling pathway used by NS3
to influence CREB Ser133 phosphorylation and CCN1
expression is worthy of investigation.
CaMKIIα, an important kinase in the Ca2+ signal-
ing pathway, was found to bind to the ZIKV NS3
protein. Further studies indicated that NS3 specifically
interacted with CaMKIIα and that NS3 was primarily
bound to the CaMKIIα regulatory domain residues
280–300 and enhanced its phosphorylation at
Thr286. In the resting state, the autoinhibitory sub-
domain of CaMKIIα binds to the catalytic domain, of
which residues 297–300 occupy the substrate binding
site of the catalytic domain and residues 282–294 bind
to the ATP binding site of the catalytic domain, inter-
fering with the binding of ATP and kinases and inhi-
biting kinase activity [61]. When Ca2+/CaM binds to
the CaM binding site of the CaMKIIα regulatory
domain, the catalytic domain of the kinase is released
to bind the substrate and ATP, thus promoting the
Thr286 site phosphorylation of the autoinhibitory
subdomain [62]. When the binding between the auto-
inhibitory subdomain and catalytic domain was
blocked by CaMKIIα Thr286 phosphorylation,
Figure 9. Schematic diagram of the mechanism by which ZIKV regulates CCN1 expression in astrocytes. We found that NS3
specifically interacted with the regulatory domain of CaMKIIα and enhanced CaMKIIα phosphorylation at the Thr286 site. Activated
CaMKIIα enhanced CREB Ser133 phosphorylation activity in the cell nucleus, which increased its association with CBP or other
transcription coactivators, thereby promoting the expression of CCN1 genes containing CRE. However, it is unclear whether CaMKIIα
directly or indirectly regulates CREB phosphorylation.
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CaMKIIα was still activated, regardless of Ca2+ [62].
We speculated that the interaction of CaMKIIα with
NS3 can lead to the continuous activation of CaMKIIα
in a Ca2+/CaM-independent manner. Studies of
chronic neuropathic pain caused by nerve injury and
inflammation have shown that activated CaMKIIα can
enhance CREB activity in the cell nucleus, thereby
altering the expression of CRE-containing genes
[63,64]. Additionally, our study indicated that NS3
overexpression could enhance the phosphorylation of
CREB Ser133 and that NS3 binding to CaMKIIα could
better stimulate CCN1 CRE activation and enhance
CCN1 transcription. Therefore, NS3 could indeed
affect CCN1 expression by activating CaMKIIα-
CREB-CRE signaling cascade through interaction
with CaMKIIα.
Furthermore, ZIKV could stimulate the phosphor-
ylation of CaMKIIα Thr286. It has been reported that
CaMKII activity is increased in nerve injury [65] and
that CaMKII promotes inflammation [66]. The
Thr286 phosphorylation site is known to be required
for autonomous CaMKIIα activities [62]. In our study,
the results of overexpression and interference demon-
strate that CaMKIIα is involved in enhancing CREB
Ser133 phosphorylation, CCN1 expression, and viral
replication. Moreover, this regulation occurred in
ZIKV infection. We hypothesize that NS3 is critical
in activating the CaMKIIα-CREB-CCN1 signaling
pathway by ZIKV to promote viral replication in
astrocytes, which is beneficial to the spread of viruses
in the CNS.
In conclusion, we demonstrated that ZIKV infection
up-regulates CCN1 protein in human astrocytes and that
the NS3-CaMKIIα-CREB pathway is critical for CCN1
up-regulation (Figure 9). Moreover, our results suggest
that the secretory CCN1 protein likely binds to receptors
on the cell membrane to regulate ZIKV replication.
Collectively, these findings elucidate the mechanisms by
which ZIKV regulates CCN1 expression may provide
information for the development of anti-ZIKV drugs.
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